Infectious Disease Diagnostic Hold Huge Potential In Reducing the Spread of Infectious Diseases. North America To Witness The Highest Growth

Infectious Disease Diagnostic Market is expected to exceed the market valuation of more than US$ XX billion by 2027 expanding at a reasonable CAGR of around XX% during the forecast period (2021-2027). There are a variety of infectious diseases and can be transmitted by a variety of ways. These diseases can be caused by bacteria, viruses, and other organisms. They can spread from one person to another through animal bites or through contaminated food or water. Most common infectious diseases include HIV/AIDS, malaria, influenza, hepatitis, and tuberculosis. One of the most common infectious disease around the world is HIV/AIDS, in 2019, 38 million people were affected by the disease. The share of most infectious diseases is much higher in low-income countries as compared to the high-income countries. This high variance is due to the unavailability of basic health facilities in lower income nations as compared to higher income nations. As the disease burden is likely to increase globally with the changing environmental factors due to global warming, the national government and private donors have a huge responsibility to prepare the health systems of lower income countries to be able to accommodate this dramatic shift.

For a detailed analysis of the Infectious Disease Diagnostic Market browse through -

Infectious diseases are mostly caused by organisms such as bacteria, viruses, parasites, or fungi. Our body inhabits many microorganisms, they are however mostly harmless to us. Infectious diseases can be passed from person to person or can be transmitted through animals. Other diseases can be transmitted through contaminated food, water or exposed to organisms in the environment. Symptoms of the diseases also vary from organism to organism and often includes fatigue and fever. Mild infections can be cured at home through rest and simple antibiotics, whereas more severe life-threatening infections require hospitalization. Many infectious diseases like chickenpox and measles are prevented through vaccines. The most common infectious diseases are respiratory infections and tuberculosis which are 43% prevalence of all the infectious diseases and HIV/AIDS and sexually transmitted infections with 26% prevalence.

Over the past year the Covid-19 pandemic has claimed many lives and disrupted many industries. Doctors and Healthcare workers have shifted their entire focus of tackling the problem at hand. However, in the midst of all this, essential services and operations focusing on the long-standing health problems like many infectious diseases around the world have taken a toll. For example, a 3 months estimate by WHO reported a 25% decrease in tuberculosis detection rate and a 13% increase in deaths due to the disease. These numbers bring us back to the numbers 5 years ago. Additionally, WHO also predicts that between 2020 and 2025 an additional 1.4 million deaths are expected because of tuberculosis as a consequence of the pandemic. Apart from tuberculosis other infectious diseases are also taking a hit due to the decreasing detection rate during the pandemic. As lives are going back to normal however, this is expected to change, and the infectious disease diagnosis industry is expected to boost its productivity and growth.

For a detailed analysis of the Product & Services in the Infectious Disease Diagnostic Market browse through -

Based on product & services the infectious diseases diagnostics market is segmented into consumables, instruments, and software & services. The consumables segment is expected showed the highest revenue and is expected to grow with the highest CAGR in the coming years. One can easily get a self-testing kit for various infectious diseases and these kits are recently gaining popularity. For example, during the coronavirus, Mylab Discovery Solutions released their self-use kits for covid virus testing which could show results in 15 minutes and costed around Rs. 250. They expect to sell 50-60 million kits a month. Since most infectious diseases are easily transmissible, self-use kits are the easiest to use. With increasing research in this area these consumables are also becoming more accurate and therefore gaining popularity.

Based on disease type, the infectious disease diagnosis market is segmented into hepatitis, human immunodeficiency virus (HIV), hospital-acquired infections (HAIS), human papillomavirus (HPV), tuberculosis (TB), influenza, and other diseases. Tuberculosis had the highest revenue among all the disease types in this segment. Tuberculosis (TB) is caused by the bacteria Mycobacterium tuberculosis which effects the lungs. In 2019, a total of 1.4 million individuals died from tuberculosis worldwide. After tuberculosis, the major infectious disease type is HIV/AIDS. As of November 2020, HIV/AIDS has claimed a total of 34.7 million lives. Diagnosis of these diseases is critical for their cure or prevention. The growing infectious disease diagnostics industry is making that possible.

For a detailed analysis of the Technology in the Infectious Disease Diagnostic Market browse through -

Based on technology, the infectious disease diagnostics market is segmented into immunodiagnostics, clinical microbiology, polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing and next-generation sequencing (NGS), DNA microarray technology, and other technologies. Immunodiagnostics had the highest revenue and CAGR growth in the analyzed period. Immunodiagnostics is a discipline that uses antigen-antibody reactions to detect molecules. This process can detect even a small number of molecules. This method has gained popularity in being a simple, fast, and accurate method in diagnosing a disease. This method can be used in detecting infectious diseases, autoimmune diseases, cancer, environment, food safety etc. The sensitivity of these tests can be 100-folds or more.

Based on End-User, the infectious diseases market is segmented into hospital/clinical laboratories, reference laboratories, academics/research institutes, and other end users. Hospitals/clinical laboratories earned the highest revenue in the infectious disease diagnostics market during the forecasted period. There are numerous laboratories in clinics and hospitals which specialize in performing diagnostic tests like blood tests, urine tests, throat swabs, etc. As of 2021, there are 29,227 Diagnostics and Medical Laboratories in the United States which is a 2% increase since 2020. There is a growth is diagnostics centers all over the world due to the emergence of the coronavirus pandemic, but in the long run this will help boost the infectious diseases diagnostics market. The other end-user segment includes home testing kits which is also gaining popularity during the pandemic when no one wants to go out.

Request for Sample of the report browse through

Additionally, the report provides detailed initiatives that are being taken in the field of Infectious Disease Diagnostic, globally. The report provide a detailed analysis of regions including North America (the U.S, Canada, and Rest of North America), Europe (Germany, France, Spain, Italy, UK, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of Asia-Pacific), and the Rest of the World. North America dominated the market in 2020, with XX% share. Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMérieux SA, Thermo Fisher Scientific Inc., Danaher Corporation, Quidel Corporation, Hologic, Inc., Siemens Healthineers AG, Becton, Dickinson and Company, PerkinElmer Inc. are some of the prominent players operating in the global Infectious Disease Diagnostic market. Several M&As along with partnerships have been undertaken by these players to make Infectious Disease Diagnostics as cost-effective and as widely available as possible.

Infectious Disease Diagnostic Market Segmentation

Market Insight, by Product & Services

  • Consumables
  • Instruments
  • Software & Services

Market Insight, by Disease Type

  • Hepatitis
  • Human Immunodeficiency Virus (HIV)
  • Hospital-Acquired Infections (HAIS)
  • Human Papillomavirus (HPV)
  • Tuberculosis (TB)
  • Influenza
  • Other Diseases

Market Insight, by Technology

  • Immunodiagnostics
  • Clinical Microbiology
  • Polymerase Chain Reaction
  • Isothermal Nucleic Acid Amplification Technology
  • DNA Sequencing and Next-Generation Sequencing (NGS)
  • DNA Microarray Technology
  • Other technologies

Market Insight, by End-User

  • Hospital/Clinical Laboratories
  • Reference Laboratories
  • Academics/Research Institutes
  • Other End Users

Market Insight, by Region

  • North America Infectious Disease Diagnostic Market
    • United States
    • Canada
    • Rest of North America
  • Europe Infectious Disease Diagnostic Market
    • France
    • Germany
    • Italy
    • Spain
    • United Kingdom
    • Rest of Europe
  • Asia-Pacific Infectious Disease Diagnostic Market
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Rest of World Infectious Disease Diagnostic Market

Top Company Profiles

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • bioMérieux SA
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Quidel Corporation
  • Hologic, Inc.
  • Siemens Healthineers AG
  • Becton, Dickinson and Company
  • PerkinElmer Inc.